Friday, March 20, 2015 11:43:31 PM
You are really doing some big time fishing here. ONCS doesn't need to clarify anything. For those who can read a PR and take at face value, it is crystal clear what Merck's role is at this point. You are trying really hard to make conjure up something that just isn't there. It is really unfortunate as I know many people read and believe your posts, and all this does is misinform the investor base and give them false expectations.
Everything you have posted so far supports exactly what me and Dr. Lowenstein are saying. The collaboration is between ONCS and UCSF. Who cares what Dr. Pierce says about the trial being unprecedented or his relationship with Merck. That has nothing to do with the topic at hand. The reason why PD doesn't talk about the relationship with Merck the way that ADXS did in their PR with Merck in the headline and quotes from Merck reps speaking about an actual "agreement", is because ONCS doesn't have one with Merck. There is nothing to report at this time.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM